What is HC Wainwright’s Estimate for RIGL Q3 Earnings?
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) – Equities researchers at HC Wainwright upped their Q3 2025 EPS estimates for Rigel Pharmaceuticals in a research note issued on Wednesday, May 7th. HC Wainwright analyst J. Pantginis now forecasts that the biotechnology company will earn $0.38 per share for the quarter, up from their previous estimate […]
